Abridge, an AI startup automating medical notes, has secured a $300 million Series E at a $5.3 billion valuation, according to the rel=”nofollow” href=”https://www.wsj.com/articles/abridge-whose-ai-app-takes-notes-for-doctors-valued-at-5-3-billion-at-funding-801825f3?gaa_at=eafs&gaa_n=ASWzDAgfSz2WouXqpZ3rLtgHapE0BOKLg7vW-VID3ttnTgq9-bIOE57HsUB4xnu5kM0%3D&gaa_ts=685aef02&gaa_sig=Bwp8K7byKvpn1JkOrwYMrCwYWiJSz6m5niQj_Uw_8l0LNHUpkxGxf_RexVenHQzsHqbjLP9TWrGiUHyspi5Wfg%3D%3D”>Wall Street Journal.   The round, led by Andreessen Horowitz with participation from Khosla Ventures, follows the company’s $250 million rel=”nofollow” href=”https://www.reuters.com/business/healthcare-pharmaceuticals/healthcare-startup-abridge-raises-250-million-enhance-ai-capabilities-2025-02-17/”>February fundraise at a $2.75 billion valuation.

Source link

Abridge, an AI startup automating medical notes, has secured a $300 million Series E at a $5.3 billion valuation, according to the rel=”nofollow” href=”https://www.wsj.com/articles/abridge-whose-ai-app-takes-notes-for-doctors-valued-at-5-3-billion-at-funding-801825f3?gaa_at=eafs&gaa_n=ASWzDAgfSz2WouXqpZ3rLtgHapE0BOKLg7vW-VID3ttnTgq9-bIOE57HsUB4xnu5kM0%3D&gaa_ts=685aef02&gaa_sig=Bwp8K7byKvpn1JkOrwYMrCwYWiJSz6m5niQj_Uw_8l0LNHUpkxGxf_RexVenHQzsHqbjLP9TWrGiUHyspi5Wfg%3D%3D”>Wall Street Journal.   The round, led by Andreessen Horowitz with participation from Khosla Ventures, follows the company’s $250 million rel=”nofollow” href=”https://www.reuters.com/business/healthcare-pharmaceuticals/healthcare-startup-abridge-raises-250-million-enhance-ai-capabilities-2025-02-17/”>February fundraise at a $2.75 billion valuation.

Source link